NP NervGen Pharma Corp. Stock: price and management transactions · Canada · SEDISource id SEDI:nervgen-pharma-corp CA · SEDI Mcap €379.7M 医疗保健 Follow the NervGen Pharma Corp. share price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Operating in the Health Care sector, NervGen Pharma Corp. has logged 27 public disclosures. Market capitalisation: €379.7m. The latest transaction was disclosed on 9 September 2026 (50 - Grant of options). Among the most active insiders: Ruffolo, John. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 September 2026
All Executives27 Thresholds0 Prospectus0 Other0
Declarations 27 total
◇ 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares @ CA$2.32 Options SEDI:4775677 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares @ CA$2.32 Options SEDI:4775662 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares @ CA$2.32 Options SEDI:4775658 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares @ CA$2.32 Options SEDI:4775655 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares @ CA$2.32 Options SEDI:4775652 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares @ CA$2.32 Options SEDI:4775646 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 4 Sept 2026
17,178 shares @ CA$2.10 Common Shares SEDI:4775644 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 4 Sept 2026
50,000 shares @ CA$2.10 Options SEDI:4775643 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
55,000 shares Options SEDI:4774792 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
50,000 shares @ CA$2.10 0.017% mcap 50.0% of flow Common Shares SEDI:4774787 ◇ 4 - Director of Issuer · Executives · 4 Sept 2026
50,000 shares @ CA$2.10 0.017% mcap 50.0% of flow Options SEDI:4774786 ◇ 4 - Director of Issuer · Executives · 28 Aug 2026
17,627 shares @ CA$2.10 0.0060% mcap 26.1% of flow Common Shares SEDI:4770513 ● 4 - Director of Issuer · Executives · 9 Sept 2021
Common Shares SEDI:4770511 ◇ 4 - Director of Issuer · Executives · 28 Aug 2026
50,000 shares @ CA$2.10 0.017% mcap 73.9% of flow Options SEDI:4770507 ◇ 4 - Director of Issuer · Executives · 24 Aug 2026
8,974 shares @ CA$2.10 0.0031% mcap 15.2% of flow Common Shares SEDI:4770502 ◇ 4 - Director of Issuer · Executives · 24 Aug 2026
50,000 shares @ CA$2.10 0.017% mcap 84.8% of flow Options SEDI:4770501 ▲ 4 - Director of Issuer · Executives · 28 Jul 2026
200 shares @ CA$1.64 0.0001% mcap 1.8% of flow Common Shares SEDI:4759712 Canonical exit: 26 Oct 2026 (T+90) ● 4 - Director of Issuer · Executives · 16 Oct 2023
Common Shares SEDI:4759711 ● 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder · Executives · 30 Jun 2026
61,713 shares @ CA$3.64 0.036% mcap 2.3% of flow Common Shares SEDI:4748874 ● 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder · Executives · 30 Jun 2026
37,784 shares @ CA$3.64 0.022% mcap 1.4% of flow Common Shares SEDI:4748871 ◇ 5 - Senior Officer of Issuer · Executives · 27 Apr 2026
812,002 shares @ CA$3.92 0.52% mcap 100.0% of flow Options SEDI:4729336 ● 5 - Senior Officer of Issuer · Executives · 27 Apr 2026
▲ 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder · Executives · 26 May 2026
800,000 shares @ CA$3.68 30.9% of flow Warrants SEDI:4727977 Canonical exit: 24 Aug 2026 (T+90) ▲ 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder · Executives · 26 May 2026
800,000 shares @ CA$2.50 21.0% of flow Common Shares SEDI:4727973 Canonical exit: 24 Aug 2026 (T+90) ▲ 4 - Director of Issuer · Executives · 27 May 2026
16 shares @ CA$2.0762 0.2% of flow Common Shares SEDI:4725857 Canonical exit: 25 Aug 2026 (T+90) 25 of 27 declarations
Load more (2 remaining) 关于 NervGen Pharma Corp. NervGen Pharma Corp. 是一家生物制药公司，专注于开发神经系统疾病的治疗方法。该公司在多伦多证券交易所上市，股票代码为XTSE。